Search

Theranostic treatment for prostate cancer involves targeting prostate specific membrane antigen (PSMA) on prostate cancer cells – first with a radioactive molecule to reveal the cancer’s spread via a PET (Positron Emission... Read more

Peter Mac has played host to the announcement of an in-principle partnership between the Victorian Government and ground-breaking German biotechnology company BioNTech. The developers of the Pfizer/BioNTech Covid-19 mRNA... Read more

We have designed the multilingual cancer glossary as a resource for professional translators, interpreters, and bilingual health professionals working in the cancer field.  This project is a Cancer Australia... Read more

This National Palliative Care Week, Australians are being asked to think and talk about something that can be hard to discuss, how we want to be cared for at the end of our life. And to help start the conversation, the... Read more

An international clinical trial involving many Peter Mac patients has shown that CAR T-cell therapy provides significant benefits compared to standard treatment of relapsed multiple myeloma. This CARTITUDE-4 study compared... Read more

Peter Mac played host to Premier Daniel Andrews and the Hon Ben Carroll, Minister for Industry and Innovation, as they announced grants for researchers to develop mRNA treatments to target prostate, bowel and breast cancers... Read more